| 2024-04-01 |
详情>>
内部人交易：
Shepko Jonathan等共交易10笔
|
| 2024-03-07 |
详情>>
业绩披露：
2023年年报每股收益-0.59美元,归母净利润-2700万美元,同比去年增长-160.67%
|
| 2024-02-15 |
股东大会：
将于2024-03-26召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of December 22, 2023 (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, TFI International Inc., a corporation incorporated pursuant to the Canada Business Corporations Act (“Parent” or “TFI”), and Diocletian MergerCo, Inc., a Delaware corporation and an indirect, wholly owned subsidiary of Parent (“Acquisition Sub”). Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, Acquisition Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger as an indirect, wholly owned subsidiary of Parent (the “Merger Proposal”);
2.To consider and vote on a non-binding, advisory proposal to approve compensation that will or may become payable to Daseke’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”);
3.To consider and vote on a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the “Adjournment Proposal”).
|
| 2024-02-15 |
详情>>
股本变动：
变动后总股本4720.03万股
|
| 2023-12-22 |
复牌提示：
2023-12-22 08:55:00 停牌，复牌日期 2023-12-22 09:50:00
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.05美元,归母净利润210.00万美元,同比去年增长-94.7%
|
| 2023-11-09 |
财报披露：
美东时间 2023-11-09 盘前发布财报
|
| 2023-08-03 |
详情>>
业绩披露：
2023年中报每股收益0.02美元,归母净利润100.00万美元,同比去年增长-96.45%
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益-0.05美元,归母净利润-220万美元,同比去年增长-118.64%
|
| 2023-04-27 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying proxy statement to serve on the Company’s Board of Directors (the “Board of Directors” or the “Board”) until the 2024 annual meeting of shareholders and until their successors are elected and qualified or their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2023;
3.To approve, on an advisory basis, the executive compensation of our named executive officers as described in “Executive Compensation”;
4.To approve an amendment and restatement of the Company’s 2017 Omnibus Incentive Plan;
5.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2023-02-23 |
详情>>
业绩披露：
2022年年报每股收益0.73美元,归母净利润4450.00万美元,同比去年增长-12.75%
|
| 2022-11-09 |
详情>>
业绩披露：
2022年三季报(累计)每股收益0.62美元,归母净利润3960.00万美元,同比去年增长-12.39%
|
| 2022-08-02 |
详情>>
业绩披露：
2022年中报每股收益0.44美元,归母净利润2820.00万美元,同比去年增长10.59%
|
| 2022-05-26 |
股东大会：
将于2022-07-06召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying proxy statement to serve on the Company’s Board of Directors (the “Board of Directors” or the “Board”) until the 2023 annual meeting of stockholders and until their successors are elected and qualified or their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2022;
3.To approve, on an advisory basis, the executive compensation of our named executive officers as described in “Compensation Overview” and the related executive compensation tables in “Executive Compensation;”
4.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2022-05-03 |
详情>>
业绩披露：
2022年一季报每股收益0.19美元,归母净利润1180.00万美元,同比去年增长238.82%
|
| 2022-02-23 |
详情>>
业绩披露：
2021年年报每股收益0.79美元,归母净利润5100.00万美元,同比去年增长6475.00%
|
| 2021-10-28 |
详情>>
业绩披露：
2021年三季报(累计)每股收益0.70美元,归母净利润4520.00万美元,同比去年增长892.98%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-07 |
股东大会：
将于2021-06-18召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in this proxy statement to serve on the Company’s Board of Directors (the “Board of Directors” or the “Board”) until the 2022 annual meeting of stockholders and until their successors are elected and qualified or their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2021;
3.To approve, on an advisory basis, the executive compensation of our named executive officers as described in “Compensation Discussion and Analysis” and related executive compensation tables;
4.To approve an amendment and restatement of the Company’s 2017 Omnibus Incentive Plan;
5.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2020-05-04 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the three directors named in this proxy statement to serve as Class II directors on the Company’s Board of Directors (the “Board of Directors” or the “Board”) until the 2023 annual meeting of stockholders (or until the 2021 annual meeting of stockholders if Proposal 5 is approved and the Declassification Amendment (as defined in the enclosed proxy statement) is filed and becomes effective as described in the enclosed proxy statement) and until their successors are elected and qualified or their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2020;
3.To approve, on an advisory basis, the executive compensation of our named executive officers as described in “Compensation Discussion and Analysis” and related executive compensation tables;
4.To approve an amendment and restatement of the Company’s 2017 Omnibus Incentive Plan;
5.To approve the adoption of an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to declassify the Board of Directors;
6.To consider and conduct an advisory vote on a stockholder proposal seeking to cause the repeal of the classification of the Board of Directors, if properly presented at the Annual Meeting;
7.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2019-07-11 |
股东大会：
将于2019-08-20召开股东大会
会议内容 ▼▲
- 1.To elect the three directors named in this proxy statement to serve as Class I directors on the Company's Board of Directors (the "Board of Directors" or "Board") until the 2022 annual meeting of stockholders or until their successors are elected and qualified;
2.To ratify the selection by our audit committee of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2019;
3.To approve, on an advisory basis, the executive compensation of our Named Executive Officers as described in "Compensation Discussion and Analysis" and related executive compensation tables;
4.To approve, on an advisory basis, the frequency for holding future advisory votes to approve the compensation of our Named Executive Officers (every 1, 2 or 3 years);
5.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2018-04-10 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the two directors named in this proxy statement to serve as Class III directors on the Company's Board of Directors (the "Board of Directors" or "Board") until the 2021 annual meeting of stockholders or until their successors are elected and qualified;
2.To ratify the selection by our audit committee of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2018;
3.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2017-11-22 |
股东大会：
将于2017-12-11召开股东大会
会议内容 ▼▲
- 1.To elect the three directors named in this proxy statement to serve as Class II directors on the Company's Board of Directors (the "Board of Directors" or "Board") until the 2020 annual meeting of stockholders or until their successors are elected and qualified;
2.To ratify the selection by our audit committee of Grant Thornton LLP to serve as our independent registered public accounting firm for the year ending December 31, 2017;
3.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2017-02-06 |
股东大会：
将于2017-02-27召开股东大会
会议内容 ▼▲
- 1.The Business Combination Proposal — to consider and vote upon a proposal to approve an agreement and plan of merger, dated as of December 22, 2016, as it may be amended (the “Merger Agreement”), by and among the Company, HCAC Merger Sub, Inc., Daseke, Inc. and Don R. Daseke, solely in his capacity as the Stockholder Representative, and the transactions contemplated thereby, which provides for the acquisition by us of all of the outstanding capital stock of Daseke, Inc. through a merger of a wholly owned subsidiary of the Company with and into Daseke, Inc., with Daseke, Inc. surviving such merger as a direct wholly owned subsidiary of the Company. We refer to Daseke, Inc. and its consolidated subsidiaries hereafter collectively as “Daseke,” and we refer to such merger and the other transactions contemplated by the Merger Agreement collectively hereafter as the “Business Combination.”
The Charter Proposals — to approve and adopt separate proposals for amendments to the Company’s amended and restated certificate of incorporation (the “existing charter”) to:
2.increase the Company’s authorized common stock and preferred stock (“Proposal 2”);
3.provide for the classification of our board of directors into three classes of directors with staggered three-year terms of office and to make certain related changes (“Proposal 3”);
4.designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for specified legal actions and provide for certain additional changes, including changing the Company’s name from “Hennessy Capital Acquisition Corp. II” to “Daseke, Inc.”, making the Company’s corporate existence perpetual and providing for severability if any clause shall be held invalid, illegal or unenforceable, which our board of directors believes are necessary to adequately address the post-Business Combination needs of the Company (“Proposal 4”);
5.to consider and vote upon a proposal to elect three directors to serve as Class I directors on our board of directors until the 2019 annual meeting of stockholders and until their respective successors are duly elected and qualified (the “Director Election Proposal”);
6.to consider and vote upon a proposal to approve and adopt the Daseke, Inc. 2017 Omnibus Incentive Plan (the “Incentive Plan Proposal”);
7.to consider and vote upon a proposal to approve, for purposes of complying with applicable Nasdaq listing rules, the issuance of more than 20% of the Company’s issued and outstanding common stock, which Nasdaq may deem to be a change of control, pursuant to the Preferred Financing and any private placement pursuant to the Backstop Commitment (the “Nasdaq Proposal”);
8.to consider and vote upon a proposal to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve the Business Combination Proposal, Proposal 2, the Director Election Proposal or the Nasdaq Proposal (the “Adjournment Proposal”).
|
| 2016-11-22 |
股东大会：
将于2016-12-20召开股东大会
会议内容 ▼▲
- 1.To elect three directors to serve as Class I directors on the Company’s Board of Directors (the “Board”) until the 2018 annual meeting of stockholders or until their successors are elected and qualified;
2.To ratify the selection by our Audit Committee of Withum Smith+Brown, PC to serve as our independent registered public accounting firm for the year ending December 31, 2016;
3.Such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2016-07-13 |
股东大会：
将于2016-07-25召开股东大会
会议内容 ▼▲
- 1. to consider and vote upon a proposal to approve an agreement and plan of merger, dated as of April 1, 2016, and amended as of July 13, 2016 (as amended, the “Merger Agreement”), by and among the Company, HCAC II, Inc., USI Senior Holdings, Inc. and North American Direct Investment Holdings, LLC, solely in its capacity as the Stockholder Representative, and the transactions contemplated thereby, which provides for the acquisition by us of all of the outstanding capital stock of USI Senior Holdings, Inc. (“USI Parent”) through a merger of a wholly owned subsidiary of the Company with and into USI Parent, with USI Parent surviving such merger as a direct wholly owned subsidiary of the Company. USI Parent, through its subsidiaries, conducts its business under the “United Subcontractors, Inc.” name. We refer to USI Parent and its consolidated subsidiaries hereafter collectively as “USI,” and we refer to such merger and the other transactions contemplated by the Merger Agreement collectively hereafter as the “Business Combination.”
The Charter Proposals — to approve and adopt separate proposals for amendments to the Company’s amended and restated certificate of incorporation (the “existing charter”) to:
2. increase the Company’s authorized common stock and preferred stock ;
3. provide for the classification of our board of directors into three classes of directors with staggered three-year terms of office and to make certain related changes;
4. designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for specified legal actions and provide for certain additional changes, including changing the Company’s name from “Hennessy Capital Acquisition Corp. II” to “USI Holdings, Inc.” and making the Company’s corporate existence perpetual, which our board of directors believes are necessary to adequately address the post-Business Combination needs of the Company
5. to consider and vote upon a proposal to approve and adopt the USI Holdings, Inc. 2016 Long-Term Incentive Plan;
6. elect for the Company not to be governed by or subject to Section 203 of the Delaware General Corporation Law, as amended (the “DGCL”);
7. to consider and vote upon a proposal to elect three directors to serve as Class I directors on our board of directors until the 2019 annual meeting of stockholders and until their respective successors are duly elected and qualified;
8. to consider and vote upon a proposal to approve, for purposes of complying with applicable Nasdaq listing rules, the issuance of more than 20% of the Company’s issued and outstanding common stock, which Nasdaq may deem to be a change of control, pursuant to the Trilantic Investment;
9. to consider and vote upon a proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve the Business Combination Proposal, the Nasdaq Proposal or the Director Election Proposal.
|